Press Release Service: ChristianaCare Gene Editing Institute Achieves CRISPR Breakthrough That Reverses Chemotherapy Resistance in Lung Cancer

Study in Molecular Therapy Oncology shows gene editing restores drug sensitivity by targeting NRF2, with potential across multiple tumor types

WILMINGTON, Del.–(BUSINESS WIRE)–In a major step forward for cancer care, researchers at…